Inventor · disambiguated record
Wei-Sheng Huang
Also filed as: HUANG WEI · HUANG WEI-SHENG
26 granted patents·32 pending applications·245 citations·filing 2006–2025
96Inventor score
Files withARIAD PHARMA INC32WANG YIHAN52ND XIANGYA HOSPITAL CENTRAL SOUTH UNIV4THESEUS PHARMACEUTICALS INC4GASHERBRUM BIO INC3
Top patents by PatentIndex Score
58 records- 0195US8114874B2Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitorsZOU Dong·Filed 2006·Granted Feb 14, 2012·53 cites·55 claims
- 0294US9273077B2Phosphorus derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2013·Granted Mar 1, 2016·13 cites·51 claims
- 0393US9029533B2Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitorsARIAD PHARMA INC·Filed 2013·Granted May 12, 2015·14 cites·17 claims
- 0493US9012462B2Phosphorous derivatives as kinase inhibitorsWANG YIHAN·Filed 2009·Granted Apr 21, 2015·28 cites·72 claims
- 0592US12291529B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2024·Granted May 6, 2025·2 cites·28 claims
- 0692US10227342B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2015·Granted Mar 12, 2019·7 cites·14 claims
- 0791US9796712B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2017·Granted Oct 24, 2017·6 cites·15 claims
- 0891US9278971B2Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitorsARIAD PHARMA INC·Filed 2014·Granted Mar 8, 2016·10 cites·11 claims
- 0991US8778942B2Substituted acetylenic imidazo[1,2-A]pyrazine compounds as kinase inhibitorsARIAD PHARMA INC·Filed 2013·Granted Jul 15, 2014·11 cites·19 claims
- 1091US8470851B2Substituted acetylenic imidazo[1,2-A]pyridine compounds as kinase inhibitorsZOU Dong·Filed 2012·Granted Jun 25, 2013·13 cites·28 claims
- 1191US8278307B2Monocyclic Heteroaryl compoundsSHAKESPEARE WILLIAM C·Filed 2007·Granted Oct 2, 2012·21 cites·28 claims
- 1291US8071609B2Unsaturated heterocyclic derivativesWANG YIHAN·Filed 2006·Granted Dec 6, 2011·20 cites·17 claims
- 1389US8461167B2Acetylenic heteroaryl compoundsWANG YIHAN·Filed 2007·Granted Jun 11, 2013·14 cites·17 claims
- 1488US11884627B2Compounds and compositions for treating conditions associated with LPA receptor activityLHOTSE BIO INC·Filed 2023·Granted Jan 30, 2024·1 cites·34 claims
- 1587US8586566B2Unsaturated heterocyclic derivativesWANG YIHAN·Filed 2011·Granted Nov 19, 2013·11 cites·19 claims
- 1686US9090561B2Acetylenic heteroaryl compoundsWANG YIHAN·Filed 2012·Granted Jul 28, 2015·9 cites·24 claims
- 1785US9834571B2Compounds for inhibiting cell proliferation in EGFR-driven cancersARIAD PHARMA INC·Filed 2016·Granted Dec 5, 2017·2 cites·16 claims
- 1884US8846664B2Pyrazinopyrazines and derivatives as kinase inhibitorsHUANG WEI-SHENG·Filed 2009·Granted Sep 30, 2014·4 cites·34 claims
- 1980US2022081440A1Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitorsARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 2078US2025361232A1Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitorsTAKEDA PHARMACEUTICALS USA INC·Filed 2025·Application pending·0 cites
- 2177US11001580B2Aminothiazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2017·Granted May 11, 2021·1 cites·14 claims
- 2277US2024208960A1Aminothiazole compounds as c-kit inhibitorsARIAD PHARMA INC·Filed 2023·Application pending·0 cites
- 2376US11117883B2Benzimidazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2017·Granted Sep 14, 2021·1 cites·7 claims
- 2475US11958850B2Heteroaryl compounds for kinase inhibitionTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Apr 16, 2024·0 cites·22 claims
- 2575US11180482B2Anilinopyrimidines as haematopoietic progenitor kinase 1 (HPK1) inhibitorsARIAD PHARMA INC·Filed 2017·Granted Nov 23, 2021·2 cites·12 claims
- 2675US2020231588A1Bicyclic Heteroaryl CompoundsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 2774US2024327404A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2024·Application pending·0 cites
- 2873US2020317705A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 2972US12428375B2Compounds and compositions for treating conditions associated with LPA receptor activityLHOTSE BIO INC·Filed 2023·Granted Sep 30, 2025·0 cites·15 claims
- 3071US11753404B2Aminothiazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2021·Granted Sep 12, 2023·0 cites·4 claims
- 3169US2019031656A1Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitorsARIAD PHARMA INC·Filed 2018·Application pending·0 cites
- 3266US9834518B2Compounds for inhibiting cell proliferation in EGFR-driven cancersDALGARNO DAVID C·Filed 2012·Granted Dec 5, 2017·2 cites·2 claims
- 3366US2024150375A1Macrocyclic compounds and uses thereofTHESEUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3465US2019218212A1Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 3564US2022064144A1Benzimidazole compounds as c-kit inhibitorsARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 3664US2020048288A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 3762US2016368917A1Bicyclic Heteroaryl CompoundsARIAD PHARMA INC·Filed 2016·Application pending·0 cites
- 3860US2025109148A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2023·Application pending·0 cites
- 3959US2017218000A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2017·Application pending·0 cites
- 4059US2024317731A1Aminothiazole compounds as c-kit inhibitorsTHESEUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4159US2024199614A1Macrocyclic egfr inhibitors for the treatment of cancerTHESEUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4258US2014364423A1Pyrazinopyrazines and Derivatives as Kinase InhibitorsARIAD PHARMA INC·Filed 2014·Application pending·0 cites
- 4356US2015166591A1Methods and compositions for raf kinase mediated diseasesARIAD PHARMA INC·Filed 2013·Application pending·0 cites
- 4454US2017369446A1Monocyclic heteroaryl compoundsARIAD PHARMA INC·Filed 2017·Application pending·0 cites
- 4554US2023148005A1Macrocyclic compounds and uses thereofTHESEUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4654US2013005738A1Monocyclic Heteroaryl CompoundsARIAD PHARMA INC·Filed 2012·Application pending·0 cites
- 4752US2016376297A1Phosphorous Derivatives as Kinase InhibitorsARIAD PHARMA INC·Filed 2016·Application pending·0 cites
- 4852US2015225436A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2015·Application pending·0 cites
- 4950US11160824B2Application of LNCRNAS ENST00000607393 siRNA in preparing preparation for treating glaucoma2ND XIANGYA HOSPITAL CENTRAL SOUTH UNIV·Filed 2018·Granted Nov 2, 2021·0 cites·3 claims
- 5048US2013178622A1Methods and Compositions for Treating CancerARIAD PHARMA INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wei-Sheng Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →